Join us Dec. 1-3 in New Orleans for the Digiday Programmatic Marketing Summit
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
The chance to win the holiday marketing season has already come and gone, per Traackr’s holiday report
The influencer marketing platform tracked the top brands according to VIT, Traackr’s proprietary metric for visibility, impact and trust.
The EU’s Digital Omnibus offers relief for ad tech, but hands more power to Big Tech and AI agents
What it means for GDPR, ad tech and the online media industry as a whole.
Future of Marketing Briefing: Bold call – the legacy influencer agency doesn’t fit the new market
The influencer shops that once drew investor enthusiasm are now ceding ground to tools that promise scale, predictability and a cleaner margin story.